ASX Filings

Opthea’s OPT-302 Granted FDA Fast Track Designation for Wet Age-Related Macular Degeneration

July 6, 2021

Additional Formats

PDF Version

Change in substantial holding

June 23, 2021

Cleansing Notice

June 22, 2021

Application for quotation of securities - OPT

June 22, 2021

Change in substantial holding

June 22, 2021

Change in substantial holding

June 22, 2021

Change in substantial holding

June 21, 2021

Proposed issue of securities - OPT

June 21, 2021

Opthea Appoints Company Secretary and Vice President of Finance

June 14, 2021

Additional Formats

PDF Version

Initial Director's Interest Notice-JH

June 7, 2021